Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae

Bacterial communities are established through a combination of cooperative and antagonistic interactions between the inhabitants. Competitive interactions often involve the production of antimicrobial substances, including bacteriocins, which are small antimicrobial peptides that target other commun...

Full description

Bibliographic Details
Main Authors: Natalie Maricic, Erica S. Anderson, AnneMarie E. Opipari, Emily A. Yu, Suzanne Dawid
Format: Article
Language:English
Published: American Society for Microbiology 2016-01-01
Series:mBio
Online Access:http://mbio.asm.org/cgi/content/full/7/1/e01656-15
id doaj-029aebf3c95841dab601e508a602a92a
record_format Article
spelling doaj-029aebf3c95841dab601e508a602a92a2021-07-02T06:48:28ZengAmerican Society for MicrobiologymBio2150-75112016-01-0171e01656-1510.1128/mBio.01656-15Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniaeNatalie MaricicErica S. AndersonAnneMarie E. OpipariEmily A. YuSuzanne DawidBacterial communities are established through a combination of cooperative and antagonistic interactions between the inhabitants. Competitive interactions often involve the production of antimicrobial substances, including bacteriocins, which are small antimicrobial peptides that target other community members. Despite the nearly ubiquitous presence of bacteriocin-encoding loci, inhibitory activity has been attributed to only a small fraction of gene clusters. In this study, we characterized a novel locus (the pld locus) in the pathogen Streptococcus pneumoniae that drives the production of a bacteriocin called pneumolancidin, which has broad antimicrobial activity. The locus encodes an unusual tandem array of four inhibitory peptides, three of which are absolutely required for antibacterial activity. The three peptide sequences are similar but appear to play distinct roles in regulation and inhibition. A modification enzyme typically found in loci encoding a class of highly modified bacteriocins called lantibiotics was required for inhibitory activity. The production of pneumolancidin is controlled by a two-component regulatory system that is activated by the accumulation of modified peptides. The locus is located on a mobile element that has been found in many pneumococcal lineages, although not all elements carry the pld genes. Intriguingly, a minimal region containing only the genes required for pneumolancidin immunity was found in several Streptococcus mitis strains. The pneumolancidin-producing strain can inhibit nearly all pneumococci tested to date and provided a competitive advantage in vivo. These peptides not only represent a unique strategy for bacterial competition but also are an important resource to guide the development of new antimicrobials.http://mbio.asm.org/cgi/content/full/7/1/e01656-15
collection DOAJ
language English
format Article
sources DOAJ
author Natalie Maricic
Erica S. Anderson
AnneMarie E. Opipari
Emily A. Yu
Suzanne Dawid
spellingShingle Natalie Maricic
Erica S. Anderson
AnneMarie E. Opipari
Emily A. Yu
Suzanne Dawid
Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
mBio
author_facet Natalie Maricic
Erica S. Anderson
AnneMarie E. Opipari
Emily A. Yu
Suzanne Dawid
author_sort Natalie Maricic
title Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
title_short Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
title_full Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
title_fullStr Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
title_full_unstemmed Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
title_sort characterization of a multipeptide lantibiotic locus in streptococcus pneumoniae
publisher American Society for Microbiology
series mBio
issn 2150-7511
publishDate 2016-01-01
description Bacterial communities are established through a combination of cooperative and antagonistic interactions between the inhabitants. Competitive interactions often involve the production of antimicrobial substances, including bacteriocins, which are small antimicrobial peptides that target other community members. Despite the nearly ubiquitous presence of bacteriocin-encoding loci, inhibitory activity has been attributed to only a small fraction of gene clusters. In this study, we characterized a novel locus (the pld locus) in the pathogen Streptococcus pneumoniae that drives the production of a bacteriocin called pneumolancidin, which has broad antimicrobial activity. The locus encodes an unusual tandem array of four inhibitory peptides, three of which are absolutely required for antibacterial activity. The three peptide sequences are similar but appear to play distinct roles in regulation and inhibition. A modification enzyme typically found in loci encoding a class of highly modified bacteriocins called lantibiotics was required for inhibitory activity. The production of pneumolancidin is controlled by a two-component regulatory system that is activated by the accumulation of modified peptides. The locus is located on a mobile element that has been found in many pneumococcal lineages, although not all elements carry the pld genes. Intriguingly, a minimal region containing only the genes required for pneumolancidin immunity was found in several Streptococcus mitis strains. The pneumolancidin-producing strain can inhibit nearly all pneumococci tested to date and provided a competitive advantage in vivo. These peptides not only represent a unique strategy for bacterial competition but also are an important resource to guide the development of new antimicrobials.
url http://mbio.asm.org/cgi/content/full/7/1/e01656-15
work_keys_str_mv AT nataliemaricic characterizationofamultipeptidelantibioticlocusinstreptococcuspneumoniae
AT ericasanderson characterizationofamultipeptidelantibioticlocusinstreptococcuspneumoniae
AT annemarieeopipari characterizationofamultipeptidelantibioticlocusinstreptococcuspneumoniae
AT emilyayu characterizationofamultipeptidelantibioticlocusinstreptococcuspneumoniae
AT suzannedawid characterizationofamultipeptidelantibioticlocusinstreptococcuspneumoniae
_version_ 1721336766097522688